![J&J and other opioid players to pay $26 billion to states over roles in addiction crisis](https://cbsnews1.cbsistatic.com/hub/i/r/2022/02/25/0425f08a-a380-45ac-9e77-21ad2fe794d0/thumbnail/1200x630/41d11d38f12291f821df520979c8a451/opioids-ap-photomatt-rourke.jpg)
J&J and other opioid players to pay $26 billion to states over roles in addiction crisis
CBSN
Drugmaker Johnson & Johnson and three major distributors finalized nationwide settlements over their roles in the opioid addiction crisis Friday, an announcement that clears the way for $26 billion to flow to nearly every state in the U.S.
Taken together, the settlements are the largest to date among the many opioid-related cases that have been playing out across the country. They're expected to provide a significant boost to efforts aimed at reversing the crisis in places that have been devastated by it, including many parts of rural America.
Johnson & Johnson, AmerisourceBergen, Cardinal Health and McKesson announced the settlement plan last year, but the deal was contingent on getting participation from a critical mass of state and local governments.
![](/newspic/picid-6252001-20250211015324.jpg)
As vaccination rates decline, widespread outbreaks of diseases like measles and polio could reemerge
Health officials in western Texas are trying to contain a measles outbreak among mostly school-aged children, with at least 15 confirmed cases. It's the latest outbreak of a disease that had been virtually eliminated in the U.S., and it comes as vaccination rates are declining — jeopardizing the country's herd immunity from widespread outbreaks.